Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Nat Rev Cancer. 2023 Jun;23(6):391-407. doi: 10.1038/s41568-023-00568-4. Epub 2023 May 3.
Metastasis has long been understood to lead to the overwhelming majority of cancer-related deaths. However, our understanding of the metastatic process, and thus our ability to prevent or eliminate metastases, remains frustratingly limited. This is largely due to the complexity of metastasis, which is a multistep process that likely differs across cancer types and is greatly influenced by many aspects of the in vivo microenvironment. In this Review, we discuss the key variables to consider when designing assays to study metastasis: which source of metastatic cancer cells to use and where to introduce them into mice to address different questions of metastasis biology. We also examine methods that are being used to interrogate specific steps of the metastatic cascade in mouse models, as well as emerging techniques that may shed new light on previously inscrutable aspects of metastasis. Finally, we explore approaches for developing and using anti-metastatic therapies, and how mouse models can be used to test them.
转移一直被认为是导致绝大多数癌症相关死亡的主要原因。然而,我们对转移过程的理解,以及我们预防或消除转移的能力,仍然令人沮丧地受到限制。这主要是由于转移的复杂性,它是一个多步骤的过程,可能因癌症类型的不同而有所不同,并且受到体内微环境的许多方面的极大影响。在这篇综述中,我们讨论了在设计研究转移的测定时需要考虑的关键变量:使用哪种转移性癌细胞来源,以及在何处将它们引入小鼠体内,以解决转移生物学的不同问题。我们还研究了用于在小鼠模型中研究转移级联特定步骤的方法,以及可能为转移的以前难以理解的方面提供新见解的新兴技术。最后,我们探讨了开发和使用抗转移疗法的方法,以及如何使用小鼠模型来测试这些疗法。